viral
agent
common
requir
immunocompromis
host
caus
infect
virus
nonliv
entiti
replic
insid
host
cell
often
use
molecular
machineri
host
genom
replic
viral
genom
consist
either
ribonucl
acid
rna
deoxyribonucl
acid
dna
compris
singl
doubl
strand
either
nucleic
acid
viral
capsid
polyhedr
structur
compos
protein
enclos
nucleic
acid
viru
virus
also
envelop
deriv
phospholipid
protein
host
cell
membran
electron
microscopi
em
use
method
identif
virus
distinct
morpholog
discuss
section
chapter
discuss
follow
point
necessari
diagnos
infect
provid
adequ
antibiot
treatment
basic
physic
chemic
structur
characterist
virus
small
entiti
nm
infect
replic
within
host
cell
use
host
cellular
machineri
synthes
new
infecti
particl
creat
progeni
virion
viru
particl
one
hand
viru
repres
inert
biochem
complex
macromolecul
sinc
replic
outsid
live
cell
howev
virus
known
infect
live
organ
inde
broad
array
virus
contribut
manifest
human
diseas
extent
infect
relat
diseas
state
depend
upon
number
virion
infect
host
well
specif
host
respons
contribut
associ
manifest
patholog
diagnosi
made
serolog
growth
cell
cultur
cytopath
effect
cpe
includ
presenc
intranuclear
intracytoplasm
inclus
immunohistochem
stain
tissu
biopsi
molecular
method
virus
contain
rna
genom
content
human
immunodefici
viru
hiv
caus
acquir
immunodefici
syndrom
aid
hiv
singlestrand
rna
viru
requir
enzym
revers
transcriptas
replic
primari
infect
consid
asymptomat
phase
viru
replic
follow
increas
viral
load
final
immun
dysfunct
aid
predomin
strain
unit
state
europ
australia
predominantli
found
west
african
nation
infect
specif
indic
aris
blood
rna
first
follow
protein
antigen
antibodi
direct
toward
epitop
replic
viru
requir
attach
glycoprotein
host
receptor
protein
attach
host
cellular
receptor
cell
bind
allow
interact
chemokin
coreceptor
site
rapid
evolut
viru
caus
viral
turnov
high
mutat
rate
patient
allow
immun
escap
transmiss
includ
sexual
contact
mucos
membran
although
rare
accident
transmiss
needl
stick
laboratori
note
congenit
hiv
occur
neonat
born
hiv
posit
mother
particularli
uncontrol
hiv
screen
test
hiv
measur
presenc
specif
antibodi
patient
serum
detect
host
expos
viru
time
window
period
enzym
immunoassay
eia
develop
time
first
third
gener
assay
new
gener
test
becom
sensit
associ
concomit
decreas
window
period
fourth
gener
test
detect
hiv
antibodi
antigen
fifth
gener
addit
differenti
antibodi
antigen
allow
assess
acut
infect
also
differenti
new
assay
decreas
window
period
almost
extent
molecular
test
either
indirect
immunofluoresc
assay
ifa
western
blot
wb
use
confirm
detect
antibodi
wb
requir
reactiv
least
two
three
follow
band
confirmatori
test
fourth
fifth
gener
assay
multispot
test
also
differenti
molecular
test
access
rna
dna
test
perform
realtim
revers
transcriptas
pcr
determin
rna
viral
load
plasma
help
stage
patient
diseas
progress
follow
respons
treatment
blood
collect
tube
contain
edta
dna
test
use
identifi
diseas
newborn
sinc
presenc
dna
indic
replic
incorpor
viru
host
cell
genom
hiv
tendenc
mutat
becom
resist
commonli
use
antivir
therefor
genotyp
phenotyp
test
often
need
guid
treatment
genotyp
assay
employ
molecular
method
identifi
virus
resist
proteas
inhibitor
nucleosid
revers
transcriptas
inhibitor
nonnucleosid
revers
transcriptas
inhibitor
integras
inhibitor
sequenc
patient
hiv
viru
phenotyp
assay
requir
growth
viru
variou
concentr
antivir
drug
determin
suscept
viru
therefor
time
consum
costli
multipl
antivir
avail
target
viral
replic
includ
nucleosid
analog
proteas
inhibitor
revers
transcriptas
inhibitor
tenofovir
disoproxilemtricitabin
new
antivir
combin
drug
contain
revers
transcriptas
inhibitor
nucleosid
revers
transcriptas
inhibitor
antivir
treat
hiv
infect
reduc
risk
hiv
transmiss
see
chapter
antibiot
antimicrobi
resist
antibiot
suscept
test
therapeut
drug
monitor
select
drug
orthomyxovirus
envelop
singlestrand
rna
virus
lipid
bilay
contain
hemagglutinin
ha
neuraminidas
na
glycoprotein
current
ha
subtyp
na
subtyp
influenza
viru
divid
type
b
c
type
b
ha
na
antigen
undergo
genet
variat
c
type
gener
antigen
stabl
influenza
initi
caus
upper
respiratori
tract
infect
spread
lower
respiratori
tract
caus
sever
desquam
bronchial
alveolar
epithelium
complic
influenza
result
pneumonia
bacteri
pneumonia
possibl
neurolog
syndrom
transmiss
occur
airborn
droplet
direct
contact
infect
patient
natur
host
viru
avian
mammalian
speci
novel
strain
influenza
occur
ha
na
antigen
chang
variou
subtyp
permit
evas
host
immun
respons
allow
reinfect
cell
cultur
previous
use
isol
diagnosi
influenza
viru
variou
cell
use
identifi
cpe
influenza
viru
includ
primari
monkey
kidney
cell
human
diploid
lung
fibroblast
human
carcinoma
cell
madindarbi
canin
kidney
cell
unfortun
cultur
requir
sever
week
presumpt
identif
presenc
influenza
viru
made
hemagglutin
use
chicken
red
blood
cell
although
virus
parainfluenza
mump
measl
produc
antigen
test
commonli
use
particularli
outpati
set
emerg
room
rapid
detect
influenza
howev
sensit
low
molecular
test
sensit
avail
format
requir
test
molecular
lab
well
perform
point
care
test
see
chapter
overview
molecular
diagnost
principl
antigen
test
molecular
method
differenti
influenza
b
howev
molecular
test
also
identifi
common
subtyp
ha
na
use
epidemiolog
purpos
treatment
influenza
oseltamivir
administ
within
hour
ill
onset
inactiv
recombin
influenza
vaccin
avail
well
nasal
spray
live
attenu
influenza
vaccin
hospit
requir
personnel
vaccin
prevent
spread
caregiv
patient
virus
belong
paramyxovirida
famili
envelop
singlestrand
rna
virus
respiratori
syncyti
viru
rsv
caus
sever
acut
lower
respiratori
tract
ill
children
includ
bronchiol
tracheobronch
pneumonia
adult
patient
atrisk
live
nurs
home
underli
heart
lung
condit
metapneumoviru
caus
common
cold
caus
lower
upper
respiratori
tract
ill
transmiss
occur
airborn
droplet
direct
contact
infect
patient
cytopatholog
effect
rsv
includ
format
multinucl
giant
cell
syncytia
cell
cultur
cell
avail
tissu
cultur
includ
human
heteroploid
cell
hela
cell
rapid
antigen
test
avail
ifa
eia
chromatograph
immunoassay
molecular
method
determin
presenc
viru
often
includ
respiratori
multiplex
assay
human
parainfluenza
hpiv
mump
viru
also
belong
paramyxovirida
famili
envelop
virus
hpiv
associ
upper
respiratori
tract
infect
pediatr
adult
patient
diseas
selflimit
reinfect
possibl
due
lack
longterm
immun
hpiv
common
caus
croup
infant
children
year
age
mump
asymptomat
case
nonspecif
respiratori
symptom
common
slightli
elev
temperatur
enlarg
parotid
gland
common
characterist
infect
hpiv
mump
transmit
via
airborn
droplet
contact
contamin
fomit
live
viru
vaccin
measl
mump
rubella
mmr
avail
molecular
method
sensit
specif
diagnosi
hpiv
differenti
type
treatment
includ
ribavirin
measl
viru
part
famili
paramyxovirida
highli
contagi
transmit
via
aerosol
measl
also
known
rubeola
occur
acut
respiratori
ill
prodrom
fever
reach
malais
cough
coryza
conjunct
pathognomon
enanthema
koplik
spot
follow
maculopapular
rash
exanthema
occur
face
upper
bodi
follow
trunk
upper
lower
extrem
lesion
persist
day
final
resolv
fine
desquam
complic
occur
includ
otiti
media
bronchopneumonia
laryngotracheobronch
diarrhea
acut
dissemin
encephalomyel
subacut
scleros
panenceph
serolog
test
measlesspecif
igm
use
diagnosi
well
molecular
method
rubella
belong
togavirida
famili
transmit
direct
contact
nasal
throat
secret
inhal
droplet
rubella
also
known
german
measl
occur
mild
maculopapular
rash
lymphadenopathi
fever
rash
start
face
last
day
complic
occur
includ
thrombocytopen
purpura
enceph
infect
pregnanc
lead
congenit
defect
infant
shed
viru
long
period
time
prenat
screen
immun
serum
igg
test
recommend
pregnant
women
initi
prenat
visit
viral
detect
made
throat
nasal
urin
sampl
molecular
method
serolog
test
presenc
rubellaspecif
igm
live
viru
vaccin
mmr
avail
flaviviru
famili
includ
west
nile
viru
dengu
viru
yellow
fever
st
loui
enceph
chikungunya
zika
viru
consid
arbovirus
origin
arthropodborn
viru
transmit
via
mosquito
flavivirus
envelop
singlestrand
rna
virus
caus
mostli
asymptomat
infect
mani
infect
asymptomat
infect
may
begin
nonspecif
febril
ill
develop
sever
lifethreaten
diseas
sinc
virus
endem
commun
diagnosi
made
antibodi
test
igg
serum
test
limit
warm
season
mosquito
viabl
characterist
variou
flaviviru
summar
tabl
virus
belong
picornavirida
famili
small
nonenvelop
virus
compris
singlestrand
rna
genom
virus
includ
famili
enteroviru
echoviru
parechoviru
polioviru
coxsacki
viru
mani
infect
asymptomat
diseas
local
system
neurolog
syndrom
includ
mening
enceph
acut
flaccid
paralysi
respiratori
syndrom
includ
common
cold
handfootandmouth
diseas
pharyng
transmiss
enteroviru
larg
fecalor
rout
except
respiratori
enteroviru
strain
transmit
airborn
droplet
enterovirus
preval
summer
fall
month
rhinoviru
occur
year
round
polioviru
spread
fecalor
rout
common
area
poor
sanit
erad
effort
decreas
polio
case
total
case
accord
polio
global
erad
initi
primari
monkey
kidney
cell
use
grow
enterovirus
cell
cultur
cerebrospin
fluid
csf
blood
respiratori
throat
swab
stool
specimen
antibodi
test
recommend
diagnosi
coxsacki
viral
myocard
sinc
strain
grow
cell
cultur
molecular
method
prefer
method
diagnosi
mening
dissemin
diseas
howev
commerci
avail
enteroviru
pcr
assay
includ
parechoviru
mostli
seen
neonat
although
support
treatment
usual
use
ribavirin
also
use
vaccin
polioviru
enterovirus
characterist
enterovirus
list
tabl
human
corona
virus
endem
human
popul
caus
agent
sever
acut
respiratori
syndrom
sar
sar
viru
symptom
includ
fever
malais
nonproduct
cough
follow
rapid
respiratori
deterior
mer
viru
also
caus
ill
high
mortal
rate
especi
patient
comorbid
symptom
includ
fever
cough
pneumonia
respiratori
deterior
molecular
method
rtpcr
avail
detect
hepat
hepa
hepat
e
hepe
virus
nonenvelop
virus
belong
differ
famili
hepa
part
picornavirida
famili
hepe
part
hepevirida
famili
hepa
hepe
commonli
seen
waterborn
outbreak
associ
contamin
food
transmit
fecalor
rout
hepa
viru
excret
high
titer
fece
allow
person
person
spread
hepe
ingest
meat
infect
anim
mainli
western
europ
japan
zoonot
infect
pig
deer
also
occur
hepa
hepe
virus
caus
viral
hepat
initi
present
fever
headach
anorexia
nausea
abdomin
discomfort
sever
diseas
older
patient
hepa
infect
cell
line
alimentari
tract
replic
liver
serolog
avail
test
vaccin
avail
prevent
hepa
viru
hepat
c
hepc
viru
part
flavivirida
famili
genu
hepadnaviru
hepc
common
blood
born
infect
unit
state
infect
rang
asymptomat
carrier
clearanc
viru
chronic
infect
chronic
infect
caus
liver
damag
lead
cirrhosi
lead
caus
liver
transplant
hepc
transmit
intraven
drug
use
multipl
sexual
partner
contact
infect
partner
diagnosi
made
initi
screen
use
serolog
posit
molecular
test
confirm
qualit
quantit
test
done
determin
presenc
viru
viral
load
respect
treatment
includ
direct
act
antivir
drug
includ
second
gener
drug
sofosbovir
viral
protein
inhibitor
well
ribavirin
hepc
viru
genotyp
may
import
determin
sever
aggress
infect
well
understand
respons
antivir
therapi
hepc
viru
genotyp
separ
six
distinct
genotyp
genotyp
common
unit
state
difficult
treat
respond
well
ribavirin
therapi
ebola
viru
marburg
virus
belong
filovirida
famili
symptom
similar
vari
greatli
individu
patient
incub
period
day
resembl
flulik
ill
follow
nausea
vomit
sore
throat
diarrhea
maculopapular
rash
follow
mucos
membran
hemorrhag
gastrointestin
bleed
death
occur
shock
day
onset
ill
viru
detect
requir
molecular
method
specimen
collect
acut
stage
ill
current
outbreak
cdc
recommend
patient
suspect
ebola
viru
test
special
laboratori
respons
network
laboratori
locat
specif
citi
addit
hospit
ask
care
patient
area
staff
engag
test
limit
equip
use
segreg
perform
dedic
place
individu
dna
virus
contain
dna
part
genet
makeup
variou
dna
virus
discuss
section
human
simplex
viru
hsv
belong
famili
herpesvirida
primari
infect
acquir
childhood
without
symptom
caus
fever
submandibular
lymphadenopathi
older
children
primari
infect
occur
herp
genitali
fever
lymphadenopathi
heal
lesion
typic
last
approxim
week
primari
infect
viru
becom
latent
dorsal
root
ganglia
recur
period
typic
associ
orolabi
recurr
genit
recurr
usual
caus
howev
genit
infect
caus
becom
common
neonat
herp
occur
vagin
deliveri
risk
infect
higher
mother
primari
infect
diseas
rang
local
infect
skin
eye
mucosa
manifest
time
occur
cn
dissemin
diseas
hsv
caus
central
nervou
system
cn
diseas
immunocompromis
host
hsv
enceph
fatal
case
without
therapi
therapi
reduc
hsv
mening
usual
selflimit
may
seen
sequela
genit
herp
hsv
mening
may
recur
case
asymptomat
period
month
year
transmiss
occur
direct
contact
secret
infect
person
incid
asymptomat
carrier
high
although
hsv
multipli
rapidli
compar
virus
grow
rabbit
kidney
cell
fast
hour
molecular
method
appropri
method
diagnosi
enceph
mening
em
imag
reminisc
round
wheel
indistinguish
herp
virus
tzanck
smear
demonstr
multinucl
giant
cell
still
use
diagnosi
fresh
untreat
unroof
skin
lesion
superfici
surfac
newborn
therapi
start
clinic
ground
earli
pcr
neg
treatment
avail
includ
acyclovir
valacyclovir
varicella
zoster
viru
vzv
part
famili
herpesvirida
varicella
chicken
pox
initi
diseas
vzv
primari
infect
occur
childhood
incub
time
day
skin
vesicl
produc
highli
infecti
vzv
becom
latent
remain
ganglia
enceph
occur
chicken
pox
occur
acut
cerebellar
ataxia
reactiv
occur
ganglion
track
sensori
nerv
area
skin
innerv
nerv
form
rash
vzv
acquir
airborn
transmiss
latent
vzv
infect
establish
dorsal
root
ganglia
although
clinic
differ
hsv
due
presenc
dermatom
rash
tzanck
smear
describ
hsv
also
use
vzv
howev
differenti
two
agent
would
possibl
use
techniqu
treatment
includ
acyclovir
cytomegaloviru
cmv
famili
herpesvirida
formal
call
cmv
asymptomat
common
viral
caus
congenit
defect
congenit
defect
includ
microcephali
intracerebr
calcif
hepatosplenomegali
cytomegal
inclus
diseas
risk
sever
birth
defect
highest
mother
primari
infect
pregnanc
cmv
opportunist
pathogen
caus
pneumon
pneumonia
mortal
treat
cn
gi
diseas
well
dissemin
diseas
occur
immunocompromis
patient
transmiss
sexual
contact
via
bodi
fluid
allow
transfer
direct
contact
infect
person
fetu
infect
via
mother
viremia
viral
ascens
cervix
cell
cultur
done
human
fibroblast
cell
cytopathogen
effect
cmv
result
intranuclear
inclus
usual
identifi
antibodi
stain
tissu
biopsi
inclus
call
owlsey
howev
due
slow
growth
viru
tissu
cultur
method
diagnosi
fallen
favor
serolog
use
test
immun
statu
pregnant
women
pretranspl
patient
howev
molecular
method
detect
viru
bodi
fluid
includ
csf
quantit
plasma
use
follow
treatment
treatment
includ
ganciclovir
valganciclovir
foscarnet
cidofovir
genotyp
resist
test
identifi
presenc
nucleic
acid
mutat
gene
mutat
encod
resist
ganciclovir
mutat
encod
resist
ganciclovir
cidofovir
foscarnet
human
herp
viru
hhv
belong
roseoloviru
genu
part
rhadinoviru
genu
associ
acut
phase
exanthema
subitum
known
roseola
symptom
sever
immunocompromis
patient
symptom
primari
infect
includ
fever
rhinorrhea
diarrhea
roseola
immunocompromis
patient
reactiv
caus
enceph
pneumon
graftversushost
diseas
bone
marrow
suppress
caus
roseola
febril
ill
seizur
children
reactiv
possibl
immunocompromis
patient
associ
form
kaposi
sarcoma
angioprolif
diseas
occur
brown
lesion
skin
intern
organ
extrem
found
saliva
therefor
airborn
transmiss
like
rout
infect
reactiv
agent
possibl
immunocompromis
patient
greater
popul
seroposit
viru
transmit
fetu
pregnanc
also
found
saliva
congenit
diseas
record
found
saliva
breast
milk
semen
transmiss
occur
inject
drug
use
blood
transfus
molecular
method
appropri
test
virus
cpe
cell
cultur
occur
multinucl
giant
cell
treatment
includ
antivir
target
includ
foscarnet
cidofovir
ganciclovir
hepat
b
hepb
part
hepadnavirida
famili
hepb
infect
hepatocyt
diseas
rang
asymptomat
acut
infect
resolv
chronic
infect
three
phase
chronic
hepat
b
viru
hbv
diseas
immun
toler
phase
immun
clearanc
phase
inact
carrier
phase
hepat
requir
hepb
replic
transmit
patient
alreadi
infect
hepb
common
mode
transmiss
mother
child
earli
childhood
infect
close
contact
sexual
contact
transfer
share
needl
intraven
drug
use
assay
avail
test
hepb
protein
specif
antibodi
serum
quantit
molecular
method
commonli
use
diagnosi
made
variou
protein
detect
cours
infect
hepb
surfac
antigen
hbsag
hepb
envelop
antigen
hbeag
present
serum
primari
infect
presenc
hbsag
use
diagnosi
presenc
hbeag
indic
viral
replic
produc
highli
infecti
patient
serolog
test
hepbspecif
antibodi
use
determin
stage
diseas
establish
immun
vaccin
first
igm
antibodi
appear
antihepat
b
core
antihbc
persist
week
initi
infect
presenc
antihb
indic
immun
infect
vaccin
acut
infect
resolv
antihb
detect
hbsag
disappear
persist
hbsag
indic
carrier
state
symptom
present
chronic
infect
patient
nearli
primari
liver
cancer
hepatocellular
carcinoma
associ
chronic
hbv
infect
treatment
includ
lamivudin
adefovir
tenofovir
telbivudin
addit
subunit
vaccin
deriv
hbsag
heb
avail
adenovirus
belong
adenovirida
famili
infect
asymptomat
caus
respiratori
infect
diarrheal
ill
symptom
includ
fever
pharyng
cervic
adenopathi
infect
includ
involv
eye
gastrointestin
tract
urinari
tract
cn
liver
genit
tract
gastroenter
normal
caus
adenoviru
serotyp
transmiss
includ
airborn
transmiss
fecalor
rout
adenoviru
grow
tissu
cultur
human
heteroploid
cell
cpe
compos
aggreg
refractil
cell
molecular
method
avail
test
done
serum
csf
respiratori
stool
sampl
treatment
includ
ganciclovir
ribavirin
cidofovir
doublestrand
dna
virus
also
includ
papillomavirus
polyomavirus
multipl
papillomavirus
oncogen
potenti
especi
high
risk
serotyp
hepat
b
viru
hpv
infect
replic
squamou
epithelium
mucos
membran
caus
benign
wart
papilloma
hpv
caus
oncogen
cervic
cancer
transmiss
occur
direct
contact
infect
epithelia
especi
sexual
contact
cytolog
exfoli
cervic
epitheli
cell
show
characterist
featur
use
papanicola
stain
cpe
character
high
nucleu
cytoplasm
ratio
molecular
test
use
diagnosi
specif
identifi
high
risk
serotyp
vaccin
avail
hpv
gardasil
merck
west
point
pa
target
hpv
type
polyomavirus
part
polyomavirida
famili
bk
viru
establish
latent
infect
kidney
shed
urin
dissemin
diseas
usual
occur
immunocompromis
patient
bk
viru
caus
renal
diseas
kidney
transplant
patient
jc
viru
caus
neurolog
symptom
progress
multifoc
leukoencephalopathi
hiv
infect
patient
poor
prognosi
infecti
spread
like
occur
via
airborn
transmiss
direct
contact
bodili
fluid
although
spread
also
occur
organ
transplant
occurr
congenit
infect
urin
cytolog
identifi
larg
cell
urin
decoy
cell
howev
diagnosi
usual
made
realtim
pcr
urin
andor
blood
jc
viru
detect
csf
molecular
method
rabi
belong
genu
lyssaviru
zoonot
diseas
caus
acut
fatal
viral
encephalomyel
transmiss
occur
small
rodent
vari
base
geographi
unit
state
rabi
transfer
skunk
california
north
south
central
state
gray
fox
texa
arizona
raccoon
east
coast
arctic
red
fox
alaska
mongoos
puerto
rico
rabi
viru
infect
cn
occur
fever
headach
weak
progress
diseas
result
insomnia
anxieti
confus
paralysi
hallucin
agit
hypersaliv
hydrophobia
death
typic
occur
within
day
onset
symptom
diagnosi
requir
saliva
serum
csf
skin
biopsi
hair
follicl
nape
neck
serum
saliva
test
antibodi
rabi
viru
skin
biopsi
examin
rabi
antigen
brain
biopsi
infect
anim
may
demonstr
rabi
inclus
negri
bodi
em
imag
show
morpholog
reminisc
bullet
characterist
dna
virus
rna
virus
summar
tabl
virus
nonliv
entiti
replic
insid
host
cell
use
molecular
machineri
host
replic
singl
doublestrand
rna
dna
glycoprotein
present
viral
capsid
surfac
interact
specif
host
membran
molecul
allow
adhes
subsequ
infect
rna
virus
hiv
caus
aid
may
found
free
viru
particl
virion
within
infect
host
cell
orthomyxovirus
envelop
singlestrand
rna
virus
lipid
bilay
contain
ha
na
glycoprotein
influenza
viru
prime
exampl
surfac
antigen
chang
pressur
immun
recognit
paramyxovirida
famili
envelop
virus
includ
parainfluenza
mump
measl
rubella
rsv
transmiss
typic
occur
airborn
droplet
direct
contact
infect
patient
picornavirida
famili
small
nonenvelop
singlestrand
rna
virus
includ
enteroviru
echoviru
parechoviru
polioviru
coxsacki
viru
clinic
symptom
postinfect
rang
respiratori
disord
rash
corona
virus
repres
agent
caus
sar
zoonot
virus
spread
via
airborn
transmiss
hepat
virus
repres
broad
group
agent
span
multipl
famili
replic
liver
result
typic
chronic
infect
dna
virus
contain
dna
common
member
class
herpesvirida
famili
includ
hsv
agent
dna
virus
includ
hepadnavirida
famili
hepat
herpesvirida
famili
varicella
zoster
cmv
transmiss
acquir
contact
bodi
fluid
typic
via
sexual
mean
roseoloviru
hhv
typic
caus
clinic
exanthem
seen
due
cpe
postinfect
host
cell
dna
virus
clinic
note
includ
adenovirus
adenovirida
famili
lead
respiratori
infect
caus
diarrheal
ill
human
papillomavirus
oncogen
capabl
polyomaviru
polyomavirida
caus
renal
neurolog
disord
molecular
diagnost
allow
rapid
detect
match
nucleic
acid
sequenc
detect
viral
antigen
releas
infect
process
detect
increas
antibodi
presenc
specif
viral
protein
common
antivir
therapeut
function
via
direct
inhibit
revers
transcriptas
altern
antivir
agent
util
nucleosid
analog
disrupt
dna
polymeras
activ
limit
virion
replic
